SCAND2P

Across TCGA pan-cancer cohorts, SCAND2P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SCAND2P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher SCAND2P RNA is associated with better overall survival. In most high-consensus cancer types, elevated SCAND2P expression acts as an unfavorable survival marker, although some lineages such as PAAD and BRCA show a favorable association.

PAAD, COAD, and ACC are the cancer types where SCAND2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.555	0.268	.001	38	view →
COAD	OS	Quartile	All	0.508	0.799	.003	36	view →
ACC	DFS	Median	All	0.304	0.621	.003	32	view →
BRCA	OS	Quartile	III,IV	0.921	0.727	.001	26	view →
UCS	DFS	Tertile	IV	0.938	0.361	.024	24	view →
READ	OS	Median	II,III,IV	0.780	0.333	.022	20	view →
LGG	OS	Tertile	All	0.606	0.385	<.001	20	view →
KIRC	DFS	Tertile	All	0.864	0.736	.019	20	view →
SKCM	DFS	Median	All	0.666	0.566	.002	20	view →
UVM	DFS	Median	III,IV	0.208	0.740	.006	16	view →
MESO	DFS	Median	IV	0.173	0.454	.009	9	view →
KIRP	DFS	Median	All	0.918	0.588	.003	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SCAND2P–PAAD (OS)

Open the PAAD breakdown →